Journal of Medical Biochemistry is a distinguished peer-reviewed journal published by the SOC MEDICAL BIOCHEMISTS SERBIA, focusing on the significant intersection of biochemistry and medicine. With an e-ISSN of 1452-8266, this Open Access journal has been enriching the academic community since 2007, providing vital insights and research findings that advance the field of medical biochemistry. Based in Belgrade, Serbia, the journal plays a pivotal role in disseminating contemporary research, highlighted by its impressive standings in the 2023 quartile rankings, featuring Q2 in Medical Biochemistry and Q3 in Clinical Biochemistry. The journal is recognized in Scopus with rankings that position it within the discerning area of medical biochemistry and clinical biochemistry, attesting to its influence and relevance. By promoting innovative research and facilitating an open exchange of scientific ideas, the Journal of Medical Biochemistry is a crucial resource for researchers, professionals, and students dedicated to uncovering the biochemical underpinnings essential to improving human health.

JOURNAL OF PEPTIDE SCIENCE, published by Wiley, is a vital resource for researchers and professionals in the fields of biochemistry, drug discovery, and molecular biology. Established in 1995 and encompassing research through 2024, this journal provides a platform for disseminating cutting-edge studies related to peptide synthesis, structure, function, and applications in therapeutics. Although it currently does not offer open access, its robust content has earned it a respectable Q3 ranking in several categories, including biochemistry and pharmacology, according to the latest metrics. Researchers will find significant insights linked to peptide chemistry and its implications in medical sciences, making the JOURNAL OF PEPTIDE SCIENCE an essential addition to academic libraries and for those passionate about peptide research and its potential breakthroughs.

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

Current Molecular Pharmacology, published by Bentham Science Publishers, is a prominent journal focused on the dynamic fields of pharmacology, drug discovery, and molecular medicine. With an ISSN of 1874-4672 and an E-ISSN of 1874-4702, this journal aims to disseminate cutting-edge research and review articles that showcase innovative methodologies and groundbreaking findings from 2008 through 2024. Holding a respectable Q3 category ranking in Drug Discovery, Molecular Medicine, and Pharmacology for 2023, Current Molecular Pharmacology serves as an essential platform for both established researchers and emerging scholars to share their insights. The journal is indexed in Scopus with its relevant ranks catering to pharmacology and molecular biology, ensuring it reaches a wide array of professionals, researchers, and students in the field. As a contributor to advancing pharmacological sciences, this journal provides invaluable access to the latest advancements and fosters ongoing dialogue in molecular pharmacology, positioning itself as a key resource in the exploration of therapeutic agents and their interactions.

PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.

Journal of Biochemistry, published by Oxford University Press, is a prestigious academic journal that has been at the forefront of biochemical research since its inception in 1922. With an ISSN of 0021-924X and an E-ISSN of 1756-2651, this journal serves as a platform for disseminating high-quality research in the fields of biochemistry, molecular biology, and medicine, holding impressive rankings such as Q2 in Biochemistry and Medicine (miscellaneous) in 2023. As of 2024, the journal continues to explore significant topics in these areas, offering valuable insights for researchers, professionals, and students alike. The journal does not currently offer open access, but it remains a vital resource for anyone in the biochemical community seeking to stay updated on the latest discoveries and advancements. With its rich history and dedication to scientific excellence, the Journal of Biochemistry is an indispensable part of the scholarly landscape.

Hormone Molecular Biology and Clinical Investigation, published by WALTER DE GRUYTER GMBH, is a pivotal journal within the realms of Endocrinology, Diabetes and Metabolism, and Molecular Biology, contributing significant insights to the field since its inception in 2010. With an ISSN of 1868-1883 and an E-ISSN of 1868-1891, this esteemed journal operates from its headquarters in Berlin, Germany. As a further testament to its growing influence, the journal has achieved respectable category quartile rankings in 2023, including Q3 in Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous), alongside Q4 in Molecular Biology. While currently not open access, the journal is dedicated to disseminating high-quality research aimed at understanding hormone-related mechanisms, clinical applications, and the biochemical pathways that underpin human health. The rich variety of articles published in Hormone Molecular Biology and Clinical Investigation make it an invaluable resource for researchers, medical professionals, and students seeking to deepen their knowledge in these critical scientific areas.

Peptide Science, published by Wiley, is an esteemed journal dedicated to advancing the understanding of peptide chemistry and its applications across various scientific disciplines, including biochemistry, biophysics, and organic chemistry. Since its inception in 2018 and continuing through 2024, this journal has provided an essential platform for the dissemination of innovative research, engaging articles, and critical reviews. With an impressive Q3 ranking in the fields of Biochemistry and Biomaterials, and a Q2 status in Biophysics and Organic Chemistry as of 2023, Peptide Science acknowledges its integral role in addressing significant scientific challenges. This open-access journal ensures that findings are readily available to a global audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. The journal exemplifies excellence in scholarly communication, making it an essential resource for anyone interested in the intricate world of peptide research.

PROSTAGLANDINS & OTHER LIPID MEDIATORS, published by Elsevier Science Inc, is a leading journal dedicated to the advancements in the field of lipid mediators, with a specific focus on prostaglandins and other bioactive lipids. This journal, indexed under ISSN 1098-8823 and E-ISSN 2212-196X, serves as a crucial platform for researchers and professionals to disseminate significant findings that span multiple disciplines, including Biochemistry, Cell Biology, Pharmacology, and Physiology. In the 2023 category quartiles, it has achieved commendable positions such as Q2 in Biochemistry and Q2 in Physiology, underscoring its importance and influence in these domains. Although it is not an open-access journal, it provides robust access options, enhancing the visibility of vital research. With its establishment in 1996, the journal continues its commitment to fostering innovative research until 2024, making it an essential resource for those involved in the dynamic realms of lipid biology and medical research.

Turkish Journal of Biochemistry-Turk Biyokimya Dergisi, published by WALTER DE GRUYTER GMBH, is a pivotal open-access journal in the field of biochemistry that serves as a forum for innovative research and scholarly discourse. Since its inception in 2009 and transitioning to open access in 2015, this journal has gained recognition within the scientific community, reflecting a commitment to advancing knowledge in biochemistry and related medical sciences. With a diverse scope that encompasses molecular biology, clinical biochemistry, and the broader arena of biochemical studies, Turkish Journal of Biochemistry offers researchers, professionals, and students access to impactful studies and current developments. Although currently positioned in the lower quartiles in specific categories, the journal aims to enhance its visibility and engagement as it converges towards a promising future, fostering collaboration and knowledge exchange among biochemists across Turkey and around the globe. This journal is vital for anyone seeking to stay abreast of emerging trends and research findings in biochemistry.